1.05
+0.02(+1.94%)
Currency In USD
| Previous Close | 1.03 |
| Open | 1.05 |
| Day High | 1.07 |
| Day Low | 1.02 |
| 52-Week High | 3.26 |
| 52-Week Low | 0.9 |
| Volume | 20 |
| Average Volume | 1.55M |
| Market Cap | 10.76M |
| PE | -1.13 |
| EPS | -0.93 |
| Moving Average 50 Days | 1.08 |
| Moving Average 200 Days | 1.43 |
| Change | 0.02 |
If you invested $1000 in Cocrystal Pharma, Inc. (COCP) 10 years ago, it would be worth $4.23 as of December 09, 2025 at a share price of $1.05. Whereas If you bought $1000 worth of Cocrystal Pharma, Inc. (COCP) shares 5 years ago, it would be worth $56.82 as of December 09, 2025 at a share price of $1.05.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 30, 2025 12:00 PM GMT
Investment by Directors and Management demonstrates confidence in the Company Potential for an additional $1.8 million upon the exercise in full of warrants BOTHELL, Wash., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (th
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
GlobeNewswire Inc.
Oct 27, 2025 12:00 PM GMT
BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I award from the National Institutes of Health (NIH)